|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2
|
Emmett MS, Dewing D and Pritchard-Jones
RO: Angiogenesis and melanoma - from basic science to clinical
trials. Am J Cancer Res. 1:852–868. 2011.PubMed/NCBI
|
|
3
|
Carlson JA, Slominski A, Linette GP, et
al: Malignant melanoma 2003: predisposition, diagnosis, prognosis,
and staging. Am J Clin Pathol. 120(Suppl): S101–S127.
2003.PubMed/NCBI
|
|
4
|
Eggermont AM: Advances in systemic
treatment of melanoma. Ann Oncol. 21(Suppl 7): vii339–344. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Griguer CE, Oliva CR, Kelley EE, Giles GI,
Lancaster JR Jr and Gillespie GY: Xanthine oxidase-dependent
regulation of hypoxia-inducible factor in cancer cells. Cancer Res.
66:2257–2263. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schmitt E, Gehrmann M, Brunet M, Multhoff
G and Garrido C: Intracellular and extracellular functions of heat
shock proteins: repercussions in cancer therapy. J Leukoc Biol.
81:15–27. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Graner MW, Cumming RI and Bigner DD: The
heat shock response and chaperones/heat shock proteins in brain
tumors: surface expression, release, and possible immune
consequences. J Neurosci. 27:11214–11227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eustace BK and Jay DG: Extracellular roles
for the molecular chaperone, hsp90. Cell Cycle. 3:1098–1100. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu X, Wang W, Shao W, et al: Heat shock
protein-60 expression was significantly correlated with the
prognosis of lung adenocarcinoma. J Surg Oncol. 104:598–603. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin C-S, He P-J, Tsai N-M, et al: A
potential role for Helicobacter pylori heat shock protein 60
in gastric tumorigenesis. Biochem Biophys Res Commun. 392:183–189.
2010.
|
|
11
|
Hwang YJ, Lee SP, Kim SY, et al:
Expression of heat shock protein 60 kDa is upregulated in cervical
cancer. Yonsei Med J. 50:399–406. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cappello F, David S, Rappa F, et al: The
expression of HSP60 and HSP10 in large bowel carcinomas with lymph
node metastase. BMC Cancer. 5:1392005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kamal A, Boehm MF and Burrows FJ:
Therapeutic and diagnostic implications of Hsp90 activation. Trends
Mol Med. 10:283–290. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Garrido C, Schmitt E, Cande C, Vahsen N,
Parcellier A and Kroemer G: HSP27 and HSP70: potentially oncogenic
apoptosis inhibitors. Cell Cycle. 2:579–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sedlackova L, Spacek M, Holler E,
Imryskova Z and Hromadnikova I: Heat-shock protein expression in
leukemia. Tumour Biol. 32:33–44. 2010. View Article : Google Scholar
|
|
16
|
Xiong Q, Jin L, Li J, et al: A Th2 immune
shift to heat shock protein 65 fails to arrest atherosclerosis:
proatherogenic role of Th2-deviated autoantibodies. Autoimmunity.
42:475–483. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ausiello CM, Fedele G, Palazzo R,
Spensieri F, Ciervo A and Cassone A: 60-kDa heat shock protein of
Chlamydia pneumoniae promotes a T helper type 1 immune
response through IL-12/IL-23 production in monocyte-derived
dendritic cells. Microbes Infect. 8:714–720. 2006.PubMed/NCBI
|
|
18
|
Chen K, Lu J, Wang L and Gan YH:
Mycobacterial heat shock protein 65 enhances antigen
cross-presentation in dendritic cells independent of Toll-like
receptor 4 signaling. J Leukoc Biol. 75:260–266. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao Y, Yokota K, Ayada K, et al:
Helicobacter pylori heat-shock protein 60 induces
interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated
protein (MAP) kinase pathway in human monocytes. J Med Microbiol.
56:154–164. 2007. View Article : Google Scholar
|
|
20
|
Jin L, Wang Y, Xiong Q, et al:
Long-lasting specific antibodies against P277 induced by mucosal
administration of P277 repeat sequences carried by Hsp65 in the
absence of adjuvants. Vaccine. 25:2043–2050. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu Y, Ouyang K, Fang J, et al: Improved
efficacy of DNA vaccination against prostate carcinoma by boosting
with recombinant protein vaccine and by introduction of a novel
adjuvant epitope. Vaccine. 27:5411–5418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guojun W, Wei G, Kedong O, et al: A novel
vaccine targeting gastrin-releasing peptide: efficient inhibition
of breast cancer growth in vivo. Endocr Relat Cancer. 15:149–159.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kreisle RA and Ershler WB: Investigation
of tumor angiogenesis in an id mouse model: role of host-tumor
interactions. J Natl Cancer Inst. 80:849–854. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiong Q, Li J, Jin L, Liu J and Li T:
Nasal immunization with heat shock protein 65 attenuates
atherosclerosis and reduces serum lipids in cholesterol-fed
wild-type rabbits probably through different mechanisms. Immunol
Lett. 125:40–45. 2009. View Article : Google Scholar
|
|
25
|
Marcatili A, Cipollaro de l’Ero G,
Galdiero M, Folgore A and Petrillo G: TNF-alpha, IL-1 alpha, IL-6
and ICAM-1 expression in human keratinocytes stimulated in vitro
with Escherichia coli heat-shock proteins. Microbiology.
143(Pt 1): 45–53. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lillicrap MS, Duggleby RC, Goodall JC and
Gaston JS: T cell recognition of a highly conserved epitope in heat
shock protein 60: self-tolerance maintained by TCR distinguishing
between asparagine and aspartic acid. Int Immunol. 16:405–414.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hartl FU and Hayer-Hartl M: Molecular
chaperones in the cytosol: from nascent chain to folded protein.
Science. 295:1852–1858. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Verdegaal ME, Zegveld ST and van Furth R:
Heat shock protein 65 induces CD62e, CD106, and CD54 on cultured
human endothelial cells and increases their adhesiveness for
monocytes and granulocytes. J Immunol. 157:369–376. 1996.PubMed/NCBI
|
|
29
|
Chin L, Garraway LA and Fisher DE:
Malignant melanoma: genetics and therapeutics in the genomic era.
Genes Dev. 20:2149–2182. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ferrara N: Role of myeloid cells in
vascular endothelial growth factor-independent tumor angiogenesis.
Curr Opin Hematol. 17:219–224. 2010.PubMed/NCBI
|
|
31
|
Shojaei F, Zhong C, Wu X, Yu L and Ferrara
N: Role of myeloid cells in tumor angiogenesis and growth. Trends
Cell Biol. 18:372–378. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang L, Chen G, Mohanty S, et al: GPR56
regulates VEGF production and angiogenesis during melanoma
progression. Cancer Res. 71:5558–5568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sekulic A, Haluska P Jr, Miller AJ, et al:
Malignant melanoma in the 21st century: the emerging molecular
landscape. Mayo Clin Proc. 83:825–846. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Carmeliet P: VEGF as a key mediator of
angiogenesis in cancer. Oncology. 69(Suppl 3): 4–10. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Verheul HM, Hammers H, van Erp K, et al:
Vascular endothelial growth factor trap blocks tumor growth,
metastasis formation, and vascular leakage in an orthotopic murine
renal cell cancer model. Clin Cancer Res. 13:4201–4208. 2007.
View Article : Google Scholar
|
|
38
|
Pugh CW and Ratcliffe PJ: Regulation of
angiogenesis by hypoxia: role of the HIF system. Nat Med.
9:677–684. 2003. View Article : Google Scholar : PubMed/NCBI
|
